These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 25799527)

  • 1. Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models.
    Maawy AA; Hiroshima Y; Zhang Y; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
    J Surg Res; 2015 Jul; 197(1):5-11. PubMed ID: 25799527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoimmunotherapy Inhibits Tumor Recurrence After Surgical Resection on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
    Hiroshima Y; Maawy A; Zhang Y; Guzman MG; Heim R; Makings L; Luiken GA; Kobayashi H; Tanaka K; Endo I; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1469-74. PubMed ID: 25893411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near infra-red photoimmunotherapy with anti-CEA-IR700 results in extensive tumor lysis and a significant decrease in tumor burden in orthotopic mouse models of pancreatic cancer.
    Maawy AA; Hiroshima Y; Zhang Y; Heim R; Makings L; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
    PLoS One; 2015; 10(3):e0121989. PubMed ID: 25799218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC).
    Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
    Pancreatology; 2015; 15(3):295-301. PubMed ID: 25800176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent and specific antitumor effect of CEA-targeted photoimmunotherapy.
    Shirasu N; Yamada H; Shibaguchi H; Kuroki M; Kuroki M
    Int J Cancer; 2014 Dec; 135(11):2697-710. PubMed ID: 24740257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
    Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
    World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model.
    DeLong JC; Murakami T; Yazaki PJ; Hoffman RM; Bouvet M
    J Surg Res; 2017 Oct; 218():139-143. PubMed ID: 28985840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.
    Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Katz MH; Fleming JB; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
    PLoS One; 2014; 9(12):e114310. PubMed ID: 25463150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreatic Cancer Therapy in an Orthotopic Mouse Model.
    Nishino H; Turner MA; Amirfakhri S; Lwin TM; Hosseini M; Singer BB; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2023 Jan; 30(1):618-625. PubMed ID: 36057899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H
    J Control Release; 2016 Jun; 232():1-8. PubMed ID: 27059723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-infrared photoimmunotherapy is effective treatment for colorectal cancer in orthotopic nude-mouse models.
    Hollandsworth HM; Amirfakhri S; Filemoni F; Molnar J; Hoffman RM; Yazaki P; Bouvet M
    PLoS One; 2020; 15(6):e0234643. PubMed ID: 32555717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.
    Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H
    Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantages of fluorescence-guided laparoscopic surgery of pancreatic cancer labeled with fluorescent anti-carcinoembryonic antigen antibodies in an orthotopic mouse model.
    Metildi CA; Kaushal S; Luiken GA; Hoffman RM; Bouvet M
    J Am Coll Surg; 2014 Jul; 219(1):132-41. PubMed ID: 24768506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
    Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Curative Fluorescence-Guided Surgery of Pancreatic Cancer.
    Bouvet M; Hoffman RM
    Hepatogastroenterology; 2015 May; 62(139):715-22. PubMed ID: 26897960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
    Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H
    Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging.
    Ito K; Mitsunaga M; Nishimura T; Kobayashi H; Tajiri H
    Oncotarget; 2016 Mar; 7(12):14143-52. PubMed ID: 26909859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.
    Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H
    PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models.
    Metildi CA; Kaushal S; Hardamon CR; Snyder CS; Pu M; Messer KS; Talamini MA; Hoffman RM; Bouvet M
    J Am Coll Surg; 2012 Jul; 215(1):126-35; discussion 135-6. PubMed ID: 22632917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cadherin-17 Targeted Near-Infrared Photoimmunotherapy for Treatment of Gastrointestinal Cancer.
    Lum YL; Luk JM; Staunton DE; Ng DKP; Fong WP
    Mol Pharm; 2020 Oct; 17(10):3941-3951. PubMed ID: 32931292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.